Association of miR-34b/c rs4938723 and TP53 Arg72Pro Polymorphisms with Neuroblastoma Susceptibility: Evidence from Seven Centers
Open Access
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Translational Oncology
- Vol. 12 (10) , 1282-1288
Abstract
No abstract availableKeywords
Funding Information
- Pearl River S and T Nova Program of Guangzhou Municipality
This publication has 55 references indexed in Scilit:
- Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastomaNature Genetics, 2012
- Interactions ofmiR-34b/candTP53Polymorphisms on the Risk of Intracranial AneurysmJournal of Immunology Research, 2012
- Phenotype Restricted Genome-Wide Association Study Using a Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma Susceptibility LociPLOS Genetics, 2011
- Integrative genomics identifies LMO1 as a neuroblastoma oncogeneNature, 2010
- A potentially functional polymorphism in the promoter region of miR‐34b/c is associated with an increased risk for primary hepatocellular carcinomaInternational Journal of Cancer, 2010
- Common variations in BARD1 influence susceptibility to high-risk neuroblastomaNature Genetics, 2009
- The MYCN oncogene is a direct target of miR-34aOncogene, 2008
- MicroRNA-34b and MicroRNA-34c Are Targets of p53 and Cooperate in Control of Cell Proliferation and Adhesion-Independent GrowthCancer Research, 2007
- A microRNA component of the p53 tumour suppressor networkNature, 2007
- The codon 72 polymorphic variants of p53 have markedly different apoptotic potentialNature Genetics, 2003